Investor Presentation for Q1FY27

Filed: 05 Aug 2026, 14:16 IST Exchange: BSE Category: Financial Results — Investor Presentation

AI summary - 1QFY27 revenue 469cr +43% YoY; EBITDA 139cr +42% YoY; EBITDA margin 30% - PAT 101cr +115% YoY; adjusted PAT margin 22% - API revenue grew ~15% YoY; Specialty CDMO strong with new client wins - Formulations revenue grew over 100% YoY; novel NorUDCA launched in India - Biologics pipeline advancing; multiple biosimilars and novel programs progressing - CDMO business expanding with integrated offerings and new late-stage projects - Capex and capacity expansions underway; multiple product launches planned FY27-FY29 - Credit rating upgraded from A+ to AA- reflecting financial strength - Management confident of stronger FY27 with robust pipeline and global partnerships

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 SHILPAMED — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SHILPAMED to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Shilpa Medicare Limited

Important. The summary above is generated automatically from Shilpa Medicare Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.